Magellan Update April 2023

BUILDERS ON SITE AT NEW LABS. The building process for Magellan’s new laboratories at Braeside has commenced. The development will include two GMP (Good Manufacturing Practice) laboratories. The factory/office complex is already complete and construction of Magellan laboratories has commenced. The first lab to be completed will be the Research and Development laboratory which will enable Magellan […]

Magellan are pleased to announce the results of our Phase 1/2 allogenic trial. The research findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI), which publishes the evidence-based, international consensus guidelines on osteoarthritis management.  

Australian Health Minister announced a $7 million grant to Magellan Stem Cells – read more here

Should you want further information regarding our results or media release please email info@magellanstemcells.com.au or call 03 9270 8080.

Investment Enquiry

Download the full Investor Presentation